| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 07/04/2007 | CN1324025C Tropane derivatives as CCR5 modulators |
| 07/04/2007 | CN1324024C Substituted thiophenes: compositions, processes of making, and uses in disease treatment and diagnosis |
| 07/04/2007 | CN1324019C New azadicyclo salt kind compound and its use in treating protein aging disease |
| 07/04/2007 | CN1324018C Oligopeptides and compositions containing them as cathepsin S inhibitors |
| 07/04/2007 | CN1324008C Novel compounds and compositions as cathepsin inhibitors |
| 07/04/2007 | CN1324006C Beta-amino acid nitrile derivs. |
| 07/04/2007 | CN1323715C Use of C-ski gene and its polypeptide in preparing medicine for improving tissue repairing and reducing scar formation |
| 07/04/2007 | CN1323693C Chinese medicinal composition for treating uroschesis and stranguria and its preparation method |
| 07/04/2007 | CN1323692C Pharmaceutical composition for treating lumbago due to kidney-asthenia and its preparing process |
| 07/04/2007 | CN1323671C Cell growth regulating factor J and its prepn process |
| 07/04/2007 | CN1323670C Cell growth regulatory factor L and preparing process thereof |
| 07/03/2007 | US7238809 Process for the preparation of inhibitors of macrophage migration inhibitory factor |
| 07/03/2007 | US7238717 S,N-diarylsulfonamide derivatives; treating inflammatory diseases such as Celiac's disease, Crohn's disease or colitis. |
| 07/03/2007 | US7238716 Alkanoic acid derivatives process for their production and use thereof |
| 07/03/2007 | US7238709 Respiratory system disorders; bronchitis; irritable bowel disorders; incontinence |
| 07/03/2007 | US7238695 Imidazolyl derivatives |
| 07/03/2007 | US7238693 Gastrointestinal disorders; central nervous system disorders; cardiovascular disorders |
| 07/03/2007 | US7238687 Nonpeptide substituted spirobenzoazepines as vasopressin antagonists |
| 07/03/2007 | US7238685 E.g., substituted 2,3,5,10b-tetraaza-benzo[e]azulen-6-yl)-acetic acids, 2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepin-5-yl)-(4,6-dimethoxy-pyrimidin-2-yloxy)-acetic acids and 2,3,4,5-tetrahydro-benzo[e][1,4]diazepin-1-ylmethyl}-benzoates; treating vasoconstriction, proliferation and inflammation |
| 07/03/2007 | US7238670 Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions |
| 07/03/2007 | US7238667 Albumin fusion proteins |
| 07/03/2007 | US7238666 Method of inhibiting fibrosis with a somatostatin agonist |
| 07/03/2007 | US7238658 Treating agonist disorders including obesity, and hyperglycemic, whole body growth, immunological, kidney, neurological and neuromuscular disorders by administering a crystal of an insulin-like growth factor-1 that diffracts x-ray radiation to produce a three-dimensional diffraction pattern |
| 07/03/2007 | US7238377 Use of an oil of the gourd family for inhibiting 5 alpha-reductase activity |
| 06/28/2007 | WO2007072911A1 Preparation with improved bioabsorbability of sapropterin hydrochloride |
| 06/28/2007 | WO2007072909A1 NOVEL OLIGONUCLEOTIDE AND NF-κB DECOY COMPRISING THE SAME |
| 06/28/2007 | WO2007072869A1 Amorphous form of 1,2-dihydropyridine compound |
| 06/28/2007 | WO2007072868A1 Crystal of 1,2-dihydropyridine compound (type iv) |
| 06/28/2007 | WO2007072782A1 Carboxylic acid derivative or salt thereof |
| 06/28/2007 | WO2007072169A2 Pharmaceutical combination for the treatment of luts comprising a pde5 inhibitor and a muscarinic antagonist |
| 06/28/2007 | WO2007072156A1 Pharmaceutical combination of a pde-5 inhibitor and a 5-alpha reductase inhibitor |
| 06/28/2007 | WO2007071653A1 Use of aminoalcohol derivatives for the treatment of overactive bladder |
| 06/28/2007 | WO2007071311A1 2 -phenylethylamino derivatives as calcium and/or sodium channel modulators |
| 06/28/2007 | WO2007027614A3 Abnormal glycosylation in tamm-horsfall protein in interstitial cystitis patient |
| 06/28/2007 | US20070149767 Agent |
| 06/28/2007 | US20070149587 Valsartan Salts |
| 06/28/2007 | US20070148688 Novel human enzymes of the metalloprotease family |
| 06/28/2007 | US20070148256 Pharmacologic-functioning water and usage of the same |
| 06/28/2007 | US20070148189 Stable Liquid Formulations of Botulinum Toxin |
| 06/28/2007 | US20070148123 Substances and agents for positively influencing collagen |
| 06/28/2007 | CA2634152A1 Trpa1 inhibitors for treating pain |
| 06/28/2007 | CA2634056A1 Amorphous form of 1,2-dihydropyridine compound |
| 06/28/2007 | CA2634019A1 Pharmaceutical combination for the treatment of luts comprising a pde5 inhibitor and a muscarinic antagonist |
| 06/28/2007 | CA2633570A1 Pharmaceutical combination of a pde-5 inhibitor and a 5-alpha reductase inhibitor |
| 06/28/2007 | CA2632780A1 Combination of r,r-glycopyrrolate, rolipram, and budesonide for the treatment of inflammatory diseases |
| 06/28/2007 | CA2632444A1 Use of aminoalcohol derivatives for the treatment of overactive bladder |
| 06/28/2007 | CA2629065A1 2 -phenylethylamino derivatives as calcium and/or sodium channel modulators |
| 06/27/2007 | EP1801120A1 Co-crystalline complex of IGF-1 and methods of identifying indirect agonists of IGF-1 using the same |
| 06/27/2007 | EP1800677A1 Preventive and/or therapeutic agent for urine collection disorder accompanying lower urinary tract obstruction |
| 06/27/2007 | EP1799650A2 Imidazole derivatives as large conductance calcium activated k channel openers |
| 06/27/2007 | EP1799633A2 Crystalline forms of (-)-(1r,2r)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol hydrochloride |
| 06/27/2007 | EP1799250A2 Use of igfbp-2 in senescence diseases and for the maintenance of organ functions |
| 06/27/2007 | EP1539181B1 Method of treating lower urinary tract disorders |
| 06/27/2007 | EP1355936B1 Polymer conjugates of neublastin and methods of using same |
| 06/27/2007 | CN1989144A N-phenylphosphoric acid triamides, method for the production thereof and their use as agents for regulating or inhibiting enzymatic urea hydrolysis |
| 06/27/2007 | CN1986568A INF-alpha expression relevant protein and its coding gene |
| 06/27/2007 | CN1985974A Chinese medicinal preparation for treating calculus and its preparing process |
| 06/27/2007 | CN1985970A Chinese medicine for chronic nephritis, chronic renal failure and other diseases |
| 06/27/2007 | CN1985941A Preparing method of micropill of six Chinese medicine materials including glutinous rehmannia |
| 06/27/2007 | CN1985897A Medicine composition for treating prostatitis and its preparing method |
| 06/27/2007 | CN1323079C Renin inhibitors |
| 06/27/2007 | CN1322883C External-use medicine for treating prostatitis |
| 06/27/2007 | CN1322876C Capsule for treating urinary system disease |
| 06/26/2007 | US7235667 N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation |
| 06/26/2007 | US7235634 Comprises proteolytic enzymes for use as tools to identify modulators for treatment and prevention of gastrointestinal, cell proliferative and inflammatory diseases |
| 06/26/2007 | US7235628 Analogues of GLP-1 |
| 06/26/2007 | US7235567 Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist |
| 06/26/2007 | US7235565 Quinoline and quinolinones 4-substituted with a 3-(hetero)cyclylcarbonyl-1-imidazolinyl or 3-(hetero)cyclylcarbonyl-1-imidazolinonyl group; treating diabetes, glomerulonephritis, endotoxic shock, psoriasis, and arthritis |
| 06/26/2007 | US7235561 Compound and a composition including such a compound |
| 06/26/2007 | US7235557 Benzo-1,5-naphthyridine and benzo-2,5-naphthyridine derivatives are used as poly(ADP-ribose) polymerase inhibitors for treating vascular stroke, cerebral ischemia, heart ischemia/reperfusion injury and gout |
| 06/26/2007 | US7235554 Water soluble; treating diseases in which peripheral benzodiazepine receptors are involved such as spinal amyotrophy, amyotrophic lateral sclerosis, cranial and medullar trauma, multiple sclerosis, and diabetic nephropathy |
| 06/26/2007 | US7235549 Benzamide, heteroarylamide and reverse amides |
| 06/26/2007 | US7235525 administering an effective amount of erythropoietin for treatment to a patient with renal failure-associated osteodystrophy or renal failure-associated osteoporosis |
| 06/26/2007 | CA2339356C Prostate formula |
| 06/26/2007 | CA2307792C Method for regulating size and growth of vascularized normal tissue |
| 06/26/2007 | CA2265464C Therapy for .alpha.-galactosidase a deficiency |
| 06/26/2007 | CA2235686C Indolin-2-one derivatives, process for their production and the pharmaceutical compositions containing them |
| 06/26/2007 | CA2215372C Bicyclic tachykinins antagonists, preparation thereof and their use in pharmaceutical composition |
| 06/26/2007 | CA2185037C Iridaceae extract and compositions containing the same |
| 06/21/2007 | WO2007069727A1 Agent for prevention and treatment of acute renal failure |
| 06/21/2007 | WO2007069712A1 Amine compound and use thereof for medical purposes |
| 06/21/2007 | WO2007069669A1 Pharmaceutical composition for enhancing adiponectin production |
| 06/21/2007 | WO2007069635A1 Vla-4 inhibitory drug |
| 06/21/2007 | WO2007039075A3 Pde inhibitors and combinations thereof for the treatment of urological disorders |
| 06/21/2007 | WO2002100330A9 METHODS OF ADMINISTERING ANTI-TNFα ANTIBODIES |
| 06/21/2007 | US20070143871 Non-human transgenic animal models for hepatocellular carcinoma |
| 06/21/2007 | US20070142476 Biphenyl-Derivatives as p38 Kinase Inhibitors |
| 06/21/2007 | US20070142470 Antidiabetic agents, antilipemic agents, dietetics, anticholesterol agents, hypotensive agents, cardiovascular disorders; (S)-Ethyl 2-methoxy-3-[4-{3-(4-methanesulfonyloxyphenyl) propylamino}phenyl]propionate |
| 06/21/2007 | US20070142352 Pteridinone Derivatives as Modulators of Chemokine Receptor Activity |
| 06/21/2007 | US20070142351 Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands |
| 06/21/2007 | US20070142342 Pharmaceutical compounds |
| 06/21/2007 | US20070142341 Use of steroid derivatives for the treatment of angiotensin ll related disease e.g. cardiovascular and proliferative disorders |
| 06/21/2007 | US20070142335 e.g. 2-amino-2-methyl-4-{1-methyl-5-[4-(3,4-dimethylphenyl)butanoyl]pyrrol-2-yl}butan-1-ol ; immunology-related disease selected from crohn's disease ulcerative colitis, multiple sclerosis, atopic dermatitis, insulin dependent diabetes mellitus, glomerular nephritis and rejection of a transplanted organ |
| 06/21/2007 | US20070142334 cancer, inflammatory, autoimmune, infectious and viral diseases , destructive bone disorders, proliferative and neurodegenerative disorders; 2-(5-fluoro-2-tolyl)-4-(4-aminocarbonylpiperazinylmethyl)-6-[a-aminocarbonyl-2,6-dichlorobenzyl]pyridine |
| 06/21/2007 | US20070142314 Administering a nucleotide decoy of an ets gene or a chimera decoy of NF-Kappa B with a hydrophillic polymer carrier sheet; aneurysm, Marfan's syndrome, aortic detachment, and plaque rupture |
| 06/21/2007 | US20070141590 Modulators of tissue regeneration |
| 06/21/2007 | US20070141149 Controlled-release pharmaceutical formulation |
| 06/21/2007 | DE60125036T2 Hydroxyformamidin-derivate und diese enthaltende medikamente Hydroxyformamidin derivatives and containing the same drug |
| 06/21/2007 | CA2633481A1 Preventive or therapeutic agent for acute renal failure |
| 06/21/2007 | CA2633374A1 Amine compound and use thereof for medical purposes |